INDUCTION HEALTHCARE GROUP PLC

Major Shareholding Notification • Apr 25, 2025

National Storage Mechanism | Additional information

RNS Number : 2546G

Induction Healthcare Group PLC

25 April 2025

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	INDUCTION HEALTHCARE GROUP PLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):      The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.	N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree	INDUCTION HEALTHCARE GROUP PLC
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:      The latest practicable date prior to the disclosure	24 April 2025
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?      If it is a cash offer or possible cash offer, state "N/A"	N/A

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
	Interests		Short positions
Number	%	Number	%
(1) Relevant securities owned and/or controlled:	Nil	Nil	Nil	Nil
(2) Cash-settled derivatives:	Nil	Nil	Nil	Nil
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	Nil	Nil	Nil	Nil
TOTAL:	Nil	Nil	Nil	Nil

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:	None
Details, including nature of the rights concerned and relevant percentages:	None

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

a) Induction Healthcare Group PLC ordinary shares held by the directors of Induction Healthcare Group PLC

Name of Director	Number Induction Healthcare Group PLC ordinary shares held	Percentage of total issued share capital (%)*
Christopher Samler	266,667	0.28%
Jane Silber	8,696	0.01%
Ian Johnson	20,000	0.02%

b) Options and awards in Induction Healthcare Group PLC held by the directors of Induction Healthcare Group PLC

Name of Induction Healthcare Group PLC Director	Number and Class of Securities Under Option	Name of Scheme or Plan	Exercise Price	Vesting Details
Paul Tambeau	350,000 ordinary shares of £0.005 each	The Induction Healthcare Non Tax Advantaged Share Option Plan	£0.005	Grant Date: 18/09/2023 Expiry Date: 18/09/2033 Initial Vesting Date: 17/01/2024 Date fully Vested: 17/01/2026
Paul Tambeau	700,000 ordinary shares of £0.005 each	The Induction Healthcare Non Tax Advantaged Share Option Plan	£0.005	Grant Date: 18/09/2023 Expiry Date: 18/09/2033 Initial Vesting Date: 23/06/2024 Date fully Vested: 23/06/2026
Paul Tambeau	500,000 ordinary shares of £0.005 each	The Induction Healthcare Non Tax Advantaged Share Option Plan	£0.005	Grant Date: 15/07/2024 Expiry Date: 15/07/2034 Initial Vesting Date: 05/07/2025 Date fully Vested: 05/07/2027
John McIntosh	500,000 ordinary shares of £0.005 each	The Induction Healthcare Non Tax Advantaged Share Option Plan	£0.005	Grant Date: 18/09/2023 Expiry Date: 18/09/2033 Initial Vesting Date: 23/06/2024 Date fully Vested: 23/06/2026
John McIntosh	350,000 ordinary shares of £0.005 each	The Induction Healthcare Non Tax Advantaged Share Option Plan	£0.005	Grant Date: 15/07/2024 Expiry Date: 15/07/2034 Initial Vesting Date: 05/07/2024 Date fully Vested: 05/07/2026

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None.

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None.

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

###### Date of disclosure:	25 April 2025
###### Contact name:	Paul Tambeau
###### Telephone number:	+44 7983 104443

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEESEDFSIEISEFL